glp 1 moa glp-1_analogs [TUSOM Frontiers | Mechanisms of action

P = 0.02) and in SELECT trial (HR 0.80

doi: 10.1097/HJH.0000000000000886

GLP-1 receptor agonist drugs (e.g., semaglutide, liraglutide, tirzapeptide) work by mimicking natural GLP-1 but last much longer

The status quo solutions employers usually deploy (e.g., generics, rebates, specialty drug carve-out programs) are no match for surging pharmacy drug costs

An extension analysis of the original STEP-1 trial (n = 327) aimed to observe weight gain and cardiometabolic effects after withdrawal of both SC semaglutide and lifestyle interventions following 68 weeks of therapy

FUNDING None ACKNOWLEDGMENTS None REFERENCES 1.Thomas MC, Brownlee M, Susztak K, Sharma K, JandeleitDahm KA, Zoungas S, et al